Nissan Chemical Corporation searching for potential collaborators at Tulane Medicine
Back in 2017, IndieBio visited Tulane University School of Medicine to meet with faculty, companies, and students. Connections happened organically, such as IndieBio offering Nick Pashos, PhD, a Tulane Bioinnovation Program student, and his startup BioAesthetics the program’s last position in their biotech accelerator program on the spot. Now in the commercialization stage, BioAesthetics wouldn't be where it is today without that 2017 meeting.
Building on the success of collaborations with leaders like IndieBio, Atomwise, Elanco, and Boehringer Ingelheim, Tulane School of Medicine is now creating a pipeline to connect scientists with industry experts. The first “House Call” event will be held on Thursday, September 19 at noon. Aziz Alejandro Abadsafian, Technology Scout for Nissan Chemical Corporation, will share industry knowledge and answer questions. Nissan Chemical’s dedicated pursuit of innovation involves forging new academic partnerships to identify and co-develop preclinical candidates ready for pharmaceutical advancement. and this is the perfect opportunity to share what’s happening at Tulane School of Medicine.
“This initiative provides a unique platform for our researchers to engage directly with leaders from Nissan Chemical Corporation and explore innovative solutions in drug discovery and development,” said Elaine Hamm, PhD, Executive in Residence at Tulane School of Medicine. “By facilitating these interactions, we aim to drive forward the future of medicine and accelerate the translation of research into impactful healthcare solutions.”
Nissan Chemical is particularly interested in the oligonucleotide space, though they remain open to exploring various therapeutic fields. The company is eager to engage with researchers working on oligonucleotides or other innovative projects addressing unmet medical needs. By sponsoring researcher projects and offering their drug discovery services at free or reduced costs, Nissan aims to foster collaborative co-development, giving researchers the extra leverage needed to kickstart projects that might otherwise be shelved. The results from these projects can be pivotal in securing larger funding sources and bringing novel treatments or cures to unaddressed illnesses.
“This event is an invaluable opportunity to explore potential collaborations,” said James Zanewicz, JD, Chief Strategy Officer for Tulane School of Medicine. “I'm beyond excited to watch as Drs. Elaine Hamm and Alexis Ducote are cranking up the volume on our prior industry collaborations into the 'House Call' series."
Register now for the first House Call on Thursday, September 19 at noon. Don't miss your chance to be part of this transformative event!
